Account
Inquiry
Tirzepatide 20mg is a novel dual GIP and GLP-1 receptor agonist developed for metabolic research applications. This synthetic peptide demonstrates significant potential in glucose regulation and weight management studies.
As a research-grade compound, Tirzepatide 20mg offers scientists a powerful tool for investigating metabolic pathways. The peptide's unique mechanism of action simultaneously targets both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
Our Tirzepatide 20mg is produced under strict GMP conditions, ensuring consistent quality and purity for research applications. The compound is supplied as a lyophilized powder in sterile vials, with comprehensive analytical documentation including HPLC and MS reports.
Key research applications for Tirzepatide 20mg include metabolic syndrome studies, obesity research, and diabetes-related investigations. The peptide's extended half-life compared to native GLP-1 makes it particularly valuable for chronic study models.
Important Note: This product is intended for research purposes only and not for human consumption. Proper handling procedures should be followed when working with peptide compounds in laboratory settings.
